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ABSTRACT 
Meloxicam is one of the oxicam anti-inflammatory drugs 
that are effective to relieve toothaches, arthritis, dysmenorrhea, 
and fever. Meloxicam in this study was milled with High Energy 
Milling (HEM) method to obtain nano size and then direct 
compression method was used to produce Orally Disintegrating 
Tablet (ODT). ODT is designed to be rapidly dissolved on the 
tongue within a minute. It can be administered without water or 
chewing and may improve the bioavailability and effectiveness of 
the drug, and increase the patient’s adherence. The present 
study aimed to understand the effects of Ac-Di-Sol and Kollidon 
CL as superdisintegrants, that were used separately or in 
combination, on the characteristics of nanoparticles meloxicam 
ODT. It was also to obtain the best proportion of combination 
between Ac-Di-Sol and Kollidon CL that can produce the optimum 
formula of meloxicam ODT. The effects of single or combined 
superdisintegrants were evaluated using Simplex Lattice Design 
(SLD). Ac-Di-Sol (X1) and Kollidon CL (X2) were independent 
variables, while dependent variables were friability (Y1), 
disintegrating time (Y2), wetting time (Y3), and percent 
meloxicam release after 60 seconds (Y4). Optimization of five 
nanoparticle meloxicam ODT formulas was conducted using 
Design Expert 7.1.5. The combination of Ac-Di-Sol 4.05mg (X1) 
and Kollidon CL 10.95mg (X2) in 150mg nanoparticles meloxicam 
ODT could produce optimal ODT characteristics. After 
verification, there was no difference between predicted value and 
observed value with p-value > 0.05.  
 
Keywords: orally disintegrating tablet (ODT), meloxicam, milling, 
nanoparticles 
 
INTRODUCTION 
Tablet is a solid dosage form 
convenience to carry, having a controllable 
duration of action. The taste and odor of the 
tablet can be improved by using certain 
techniques. However, geriatric and pediatric 
patients may experience difficulty in swallowing 
conventional tablets even with water (Koseki et 
al., 2009). Orally disintegrating tablet (ODT) 
benefits those patients because it rapidly 
dissolves in the mouth (Rahman et al., 2010). 
The volume of saliva required to disintegrate 
this type of tablet was minimum. The 
disintegrated tablet was then partly or 
completely absorbed into systemic circulation 
throughout blood vessels in the sublingual 
mucosa or it can be swallowed so that it 
dissolves and is absorbed in the gastrointestinal 
tract (Singh, 2009; Hirani et al., 2009). 
Bioavailability of several drugs can be increased 
by ODT due to the increase of dissolution rate 
(Ahmed dan Aboul, 2007). 
The primary criterion of ODT is rapid 
dissolution or disintegration inside the mouth, 
hence ODT should be ultimately formulated 
by direct compression method and contained 
high concentration of superdisintegrant. The 
concentration of superdisintegrant was 
determined based on the ODT characteristics, 
the amount of active ingredient, and desired 
drug release profile. Therefore, selecting 
appropriate type and amount of 
superdisintegrant are an important initial step 
in the ODT development (Camarco et al., 
2006). In this research, two superdisintegrants 
Ac-Di-Sol and Kollidon CL were selected. 
Simplex Lattice Design was used to determine 
the optimum proportion of both 
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superdisintegrants. The next criterion of ODT 
is the use of hydrophilic components, 
particularly the active ingredient (Sharma et al., 
2005).  
Meloxicam was used as the active 
component of ODT in this research. It is a 
non-steroidal anti-inflammatory drug (NSAID) 
that inhibits cyclo-oxygenase 2 (COX-2) and is 
used in the treatment of osteoarthritis and 
rheumatoid arthritis (Mahrouk et al., 2009). 
Meloxicam is classified under class II of 
Biopharmaceutics Classification System (BCS), 
having good permeability, but low solubility or 
practically insoluble in the water. Hence, the 
ODT formulation of meloxicam is a great 
challenge. The solubility of meloxicam in the 
water is 0.011mg/mL (Saleem et al., 2010). An 
additional step is needed to increase the 
solubility of meloxicam, such as significantly 
reducing the particle size of meloxicam into 
nano size, which is widely known as 
nanoparticles.  
Nanoparticles can be obtained using 
several methods and the most common one is 
media mill (Möschwitzher and Müller, 2007). 
Microparticles of meloxicam were turned into 
nanoparticles by using high energy milling 
(HEM) E3D. The nanoparticles were then 
evaluated using scanning electron microscope 
(SEM), particle size analyzer (PSA) dan X-ray 
diffraction (XRD). The particles yielded from 
milling were formulated to become ODT, 
which was then characterized using several 
tests including weight variation, uniformity of 
tablet content, hardness, friability, disintegrating 
time, wetting time, and in vitro dissolution. 
Previous research studied the use of wet 
granulation to produce meloxicam ODT 
(Kulkarni et al., 2010), the use of sublimation 
(Elbary et al., 2012) and solid dispersion 
(Singhvi et al., 2013) methods to increase            
the dissolution rate of meloxicam ODT,           
and the use of ion exchange and complexation 
with cyclodextrin to mask the taste of 
meloxicam ODT (Samprasit et al., 2013). To  
the authors knowledge, literature search found 
no study that explores the effects of different 
superdisintegrants on the characteristics of 
nano-meloxicam ODT. Therefore, five 
formulas   with   different   proportion   of         two  
superdisintegrants would be optimized in this 
study. The optimum formula would be verified 
and analyzed using OpenStat software. 
 
MATERIALS AND METHODS 
Meloxicam was purchased from 
Zhejiang Exel China and Ac-Di-sol was from 
FMCBiopolymer, Ireland. Kollidon CL was 
granted by BASF, Germany. Avicel pH 102 and 
aspartame were from Mingtai Chemical Co. 
Ltd., Taiwan and Vitasweet Co., Ltd., 
respectively. Mg stearate was ordered from  
Bratachem, Indonesia. Mannitol, talcum, and 
other compounds were either pharmaceutical 
or analytical grade. 
 
Preparation of meloxicam nanoparticles 
with High Energy Milling (HEM) 
An amount of 5g meloxicam with a 
particle size of 4.057µm and ceramic balls with 
2mm of diameter were inserted into a chamber 
with 1:10 ratio. HEM E3D was then operated 
at 1400rpm for 48h to yield meloxicam  
particles with size less than 1000nm. Particles 
of the product were characterized using 
scanning electron microscope (SEM), X-Ray 
diffractometer, and particle size analyzer (PSA). 
 
UV Spectrum analysis of meloxicam 
At first, a 100µg/mL standard stock 
solution was prepared by inserting 10.0mg 
meloxicam into a 100.0mL flask. 5.0mL 
methanol and 1.0mL NaOH 0.1N were then 
poured into the flask and this mixture was 
diluted with phosphate buffer pH 6.8 up to 
10.00 mL. A 10µg/mL solution for scanning 
was made from a 1.0mL standard stock 
solution that was diluted with phosphate buffer 
pH 6.8 up to 10.0mL. Because meloxicam 
absorbs UV at maximum λ of 362nm, scanning 
was conducted at λ 200-400nm. 
 
Calibration curve of meloxicam 
A standard curve was made by using a 
series of meloxicam concentration of 4, 8, 12, 
16, 20, and 24µg/mL from the stock solution 
100µg/mL. A UV/Visible spectrophotometer 
(Genesys 10UV Scanning, Thermo Electron 
Scientific Instrument Corporation, USA) was 
used to measure absorbance. A plot of 
absorbance and concentration was then made. 
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Preparation of nanoparticles meloxicam 
ODT 
ODT of nanoparticle meloxicam was 
formulated by using two superdisintegrants, 
Ac-Di-Sol and Kollidon CL, that were 
optimized by using Simplex Lattice Design and 
analyzed with Design Expert Software 7.1.5. 
The highest and the lowest level of each 
superdisintegrant were 15mg and 0mg, 
respectively. Tablet was directly compressed 
according to formulas (Table I).  
Each material was weighed, inserted into 
a mortar and then homogeneously mixed for 
10min. Magnesium stearate and talc were the 
lubricants of the mixture. Pre-formulation 
characteristics of the homogeneous mixture 
were examined before being compressed with 
single punch machine (Korch PE 246 SRC, 
Germany). 
 
Bulk density 
Loose bulk density (LBD) and tapped 
bulk density (TBD) were measured using 
tapped density tester (Banker and Anderson, 
1986).  
Bulk density was calculated according to this 
equation: 
 
..................................................(1) 
Reduced volume due to tapping was stated as 
tapped density value: 
 
.................................................(2) 
 
Carr’s index of mixed powder was 
calculated by using the following equation 
(Banker dan Anderson, 1986): 
 
..........(3) 
 
Where, LBD = weight of powder/bulk volume 
of powder; TBD = weight of powder/tapped 
volume. 
 
Hausner Ratio 
Hausner ratio is an indirect index to 
evaluate the characteristics of powder flow, and 
it is calculated by using the equation below: 
 
......................(4) 
The Hausner ratio value of less than 1.25 
indicates that powder flow is good (Bhowmik et 
al., 2009). 
 
Evaluation of water absorption capacity 
of mixed powder (Granules) 
Water absorption capacity tester was 
connected with electronic balance on which an 
infusion bag was set up above it. The position 
of the infusion bag inside the balance was 
carefully set up so that the bag did not touch 
the capillary pipe that was connected to the 
granules. The bag was filled with water until the 
height of its surface was at the same level with 
the surface of water inside the tube. Filter paper 
was placed on the tube and also above the 
granule holder. The amount of reduced water 
from ampoule (ARWFA) after 15min was 
recorded. 
 
Water Absorption Rate =  
ARWFA 
Absorption Time  
……………..(5) 
Table I. Simplex lattice design for formulation  
 
Materials (mg) F1 F2 F3 F4 F5 
Nanoparticle meloxicam 6.28* 6.28* 6.28* 6.28* 6.28* 
AC-Di-Sol 15 3.75 0 7.5 11.25 
Kollidon CL 0 11.25 15 7.5 3.75 
Avicel PH 102 100 100 100 100 100 
Mannitol 24 24 24 24 24 
Aspartam 2 2 2 2 2 
Magnesium stearate 0.15 0.15 0.15 0.15 0.15 
Talcum 1.35 1.35 1.35 1.35 1.35 
TOTAL 150 150 150 150 150 
 
  *6.28mg meloxicam nanoparticles equal to 7.5mg meloxicam 
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Characterization of nanoparticle 
meloxicam ODT 
Average weight and weight variation 
A number of 20 tablets from each 
formula was weighed one by one using analytical 
balance. The average weight, coefficient of 
variation, and standard deviation was calculated 
(Indonesia Pharmacopeia, 2014).  
 
Evaluation of Content Uniformity  
A number of ten tablets from each 
formula were taken, powdered one by one and 
then inserted into a 100.00mL beaker glass. 
Five mL of methanol and 1.0mL of NaOH 
0.1N was added to the beaker and then diluted 
with phosphate buffer with pH 6.8 up to 
100.00mL. The concentration was measured 
with a UV spectrophotometer. The average 
concentration and coefficient of variation        
were calculated (Indonesia Pharmacopeia, 
2014). 
 
Hardness Test 
Hardness test was carried out using 
Stokes Monsato hardness tester by taking six 
tablets randomly from each formula. The 
hardness value was measured and stated as 
mean+SD. A good ODT formulation should 
have hardness value in a range of 3-5kg/cm2 
(Panigrahi dan Behera, 2010). 
 
Friability Test  
A number of 20 nanoparticle meloxicam 
ODT tablets were dedusted and weighed to 
define its initial weight. The friability tester 
(Erweka friabilator abrasive tester, Erweka type 
T.A.P, Germany) was rotated at a speed of 
25rpm for 4min. The tablets were dedusted and 
weighed again to obtain their final weight 
(Lachman et al., 1994). The friability of tablet 
was calculated according to the following 
equation: 
 
% Friability = 
Initial Weight – Final Weight 
 X 100 
Initial Weight 
...........(6) 
 
Disintegration Test  
Tablets were sunk in a 10-cm-diameter-
petri dish containing 10mL water with a 
temperature of 25OC. Disintegrating time of 
each of six tablets was recorded and the  
average value was calculated later (Gohel et al., 
2004). 
 
Wetting Time  
A filter paper was folded twice and put 
on a 5-cm-diameter-petri dish containing 5mL 
aqua dest with FDC strawberry red/methylene 
blue dye. A tablet was gently placed on the 
filter paper. The time needed for the tablet 
surface to become red/blue was noted as 
wetting time. The test was repeated three times 
(Tanuwijaya et al., 2014). 
 
In vitro dissolution study  
The study was undertaken by placing 
ODT into a 900mL dissolution medium, which 
was phosphate buffer pH 6.8, using USP type 
II apparatus (Erweka type D-63150, Germany) 
at 50rpm and 37±0.5°C. Sampling was 
performed during the 1st, 3rd, 5th, 10th, 15th, 20th, 
25th, and 30th min by taking a 5.0mL medium, 
filtering it, and pouring fresh 5.0mL medium 
into the dissolution chamber. Absorbance was 
measured at λ 361.5nm using a UV-Vis 
spectrophotometer (Genesys 10UV Scanning, 
Thermo Electron Scientific Instrument 
Corporation, USA). The concentration of drug 
release was calculated (Indonesia Pharmacopea, 
2014). 
 
RESULTS AND DISCUSSION 
Analysis of Meloxicam Nanoparticle Size 
Initial results of measurement of 
meloxicam particle showed its size of 4057.4nm 
with monodisperse characteristic. Milling was 
performed to decrease the particle size of 
meloxicam until it reached < 1µm. This may 
improve the solubility of meloxicam as it would 
be formulated to become rapid dissolving 
tablet. 
Measured by Particle Size Analyzer 
(DelsaTM Nano, Beckmann Coulter), milled 
meloxicam powder showed particle size 
reduction from 4057.4nm to 372.6nm with 
polydispersity index of 0.295 (Figure 1). This 
proves that milling can reduce the particle size 
of meloxicam and therefore it can be expected 
that solubility, bioavailability, and the onset of 
action of meloxicam will be more rapid to 
relieve pains due to arthritis or rheumatic 
diseases, for instances.  
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Morphological analysis of particles of 
nanoparticle meloxicam  
Morphological analysis of meloxicam 
particles was done with Scanning Electron 
Microscopy (SEM). Meloxicam particles 
appeared coarse and amorphous (Figure 2). 
SEM analysis was also used to examine whether 
morphological changes of meloxicam happened 
after milling. Figure 2 (B) shows that aggregation 
of meloxicam nanoparticles occurred, resulting 
in a seemingly greater size of nanoparticles than 
macroparticles. 
 
Analysis of meloxicam nanoparticles 
with XRD 
X-Ray diffraction showed that both 
meloxicam microparticles and nanoparticles 
had five peaks in the areas of 10-30 degrees 
(2θ). The similarity between both demonstrated 
that the particles being analyzed were 
meloxicam (Figure 3). The differences between 
both were on intensity and width of the peaks. 
These proved that milling can change the  
particle size. Widened peak indicates smaller 
crystal size. The reduction of crystal size may 
because of conduction or loss of mechanical 
energy during milling process (Bustos et al., 
2007). 
 
UV spectrum analysis of meloxicam 
The maximum λ of meloxicam was 
found 364nm from UV scanning. Good 
standard curve requires a five-series-
concentration in which linearity is the ability of 
an analytical procedure to result in proportional 
absorbance response or having a good 
correlation with analyte concentration within a 
defined range (ICH, 2005). The analytical 
method is said to be linear if within a certain 
range it has a correlation coefficient (r) >0.99 
and determination coefficient (R2) >0.995. 
Figure 4 shows a linear regression equation of 
y= 0.0581x-0.0271 with R2 = 0.9982. As those 
two values were close to 1, it can be concluded 
that there was a strong correlation between 
analyte and response. 
 
 
Figure 1. Particle size of meloxicam after treatment with HEM, measured with PSA 
 
 
 
Figure 2. (A) Microparticles of meloxicam, 500x magnification (B) Nanoparticles of meloxicam, 
500x magnification 
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Evaluation of flow of granules and 
water absorption capacity 
Before being compressed to become 
tablets, the characteristics of homogenized 
granules were examined (Table II). The bulk 
density of granules was in a range of 0.38±0.02 
to 0.41±0.01, whilst the tapped density was in 
between 0.48±0.01 and 0.51±0.00. Carr’s index 
value of F1-F5 showed satisfactory flow 
properties (Banker dan Anderson, 1986), and 
therefore they suited to be processed into an 
orally disintegrating tablet by direct 
compression method. Hausner ratio that was in 
between 1.24±0.02 to 1.28±0.05 also indicated 
good flow properties.  
Water absorption capacity affects 
disintegration process of tablets. Among five 
formulas of pre-compression granules (Table 
II), the formula with single superdistegrants 
Ac-Di-Sol (F1) had the highest rate of water 
absorption. This is because Ac-Di-Sol is a 
croscarmellose sodium that its structure is built 
from glucose polymer so that it has a great 
capacity to absorb water and rapidly swells. On 
the other hand, Kollidon CL is a crospovidone 
that has a hygroscopic cross-linking polymer 
that increases water absorption capacity of 
granules (Quadir dan Kolter, 2006). 
 
Evaluation of physical parameter of 
meloxicam nanoparticles ODT 
Weight variation  
The weight variation of ODT complied 
with the requirements of the 3rd edition of 
Indonesia Pharmacopeia stating that among 
tablets with a weight of 150mg each, there 
cannot be two or more tablets that have 10% 
deviation or a tablet that has 20%          
deviation from the average weight. In fact, the 
coefficient of variation  of  all  formulas was  <2%  
 
 
Figure 3. X-Ray diffraction of (A) meloxicam microparticles and (B) nanoparticles 
 
 
 
Figure 4. Standard curve of meloxicam 
 
 
 
Figure 5. Comparative drugs release profile of five ODT formulations 
Lina Winarti 
Volume 28 Issue 1 (2017) 59 
(Indonesia Pharmacopeia, 2014), as shown in 
Table III. This is due to the satisfactory flow 
characteristics of all formulas that ensure the 
uniformity of powder entering the die.  
 
Content uniformity of meloxicam ODT 
The present content uniformity test 
aimed to know whether the content of each 
meloxicam ODT is in line with the 
requirements in the monograph. If the ODT 
fails to meet the requirements, its therapeutic 
effectiveness will not be achieved. The results 
showed that the average weight of meloxicam 
in all formulas (Table III) ranged between 
98.02±4.45% and 104.22±2.27%, thus meeting 
the requirements of the USP XXXVII (2014) 
that suggests meloxicam must be in a range of 
90-110%. 
 
Tablet hardness  
Tablet hardness is a parameter that 
represents the overall tablet resistance towards 
mechanical forces due to crash or collision with 
other objects during packaging, storage, and 
distribution to consumers. The hardness is also 
associated with disintegrating time. ODT 
hardness, approximately 3-5kg/cm2, is lower 
than conventional tablets, approximately 4-
8kg/cm2 (Panigrahi dan Behera, 2010). The 
results from all formulas met the requirements 
in a range of 3-5kg/cm2 (Table III). It can be 
concluded that the nano-meloxicam ODT was 
fairly resistant to the mechanical collision. 
 
Effect of  independent variables on 
friability  
Tablet friability represents the strength 
of particle bonding on the tablet surface to the 
effects of friction or abrasion. The friability of a 
tablet must not be more than 1% (Panigrahi 
dan Behera, 2010). The results demonstrated 
that all formulas met the friability requirement 
(Table III).  
Friability data in Table III can be made 
in an equation which can be seen at Table IV 
and the contour plot can be seen at Figure 6. 
According to the equation (7), Ac-Di-Sol 
increased friability more than Kollidon CL. The 
combination of both reduced friability, 
indicated by the negative sign in the equation. 
Hence, it is understood that the use of Ac-Di-
Sol in higher percentage may yield a tablet with 
Table II. Evaluation results of granules flow and water absorption capacity 
 
Formula 
Name 
Bulk Density 
(g/mL) 
Tapped Density 
 (g/mL) 
Carr’s Index  
(%) 
Hausner’s  
Ratio 
Water absorption 
capacity (g/min) 
1 0.41±0.01 0.51±0.00 19.17±1.44 1.24±0.02 0.12±0.00 
2 0.38±0.02 0.48±0.01 20.00±2.50 1.25±0.04 0.09±0.01 
3 0.39±0.01 0.49±0.01 20.00±2.50 1.25±0.04 0.08±0.00 
4 0.39±0.00 0.50±0.02 21.67±2.89 1.28±0.05 0.08±0.02 
5 0.39±0.00 0.50±0.02 21.67±2.89 1.28±0.05 0.06±0.00 
 
Table III. Physical characteristics of Nanoparticle meloxicam ODT 
 
Parameter 
Formulation Code 
F1 F2 F3 F4 F5 
Weight variation (mg) 149.30±1.08 149.75±1.12 150.05±0.94 149.90±1.06 150.25±1.33 
CV of Tablets weight (%) 0.007 0.007 0.006 0.007 0.009 
Drug Content (%) 102.77±4.28 102.53±3.46 101.64±2.99 104.22±2.27 98.02±4.45 
Hardness (kg/cm2) 4.17±0.14 4.12±0.12 4.15±0.10 4.13±0.12 4.12±0.10 
Friability (%) 1.03±0.34 0.66±0.04 0.75±0.21     0.63±0.19 0.67±0.29 
Disintegration Time (s) 17.50±1.44 14.45±2.61 17.31±1.21 13.28±0.66 14.25±1.25 
Wetting Time (s) 8.72±0.14 23.60±0.26 27.23±0.72 16.06±0.98 12.99±0.97 
Cumulative of meloxicam 
released at 60 seconds (%) 
79.85±3.32 89.52±3.82 59.15±5.97 63.4±3.96 47.08±3.28 
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high % of friability (Wiradjaja et al., 2015). 
Model terms for friability were found to be 
insignificant on a quadratic model with F value 
of 13.15 dan p-value of 0.071, which is more 
than 0.05. However, all formulas had % friability 
less than 1%, which fulfilled the requirement.  
 
Effect of  independent variables on 
wetting time 
The shorter the wetting time, the easier a 
tablet to disintegrate (Hirani et al., 2009). All 
five formulas showed wetting time was less 
than a minute (Table III), and therefore it can 
be expected that they could readily disintegrate 
after they were placed in the mouth. Wetting 
time data in Table III can be made in equation 
(Table IV). The contour plot of wetting time 
can be seen in Figure 6. 
According to the equation (8), Kollidon 
CL was more dominant than Ac-Di-Sol in 
accelerating the wetting process because 
Kollidon CL is hygroscopic and has the porous 
structure that facilitates water absorption 
(Mohamed et al., 2012; Kornblum and Stoopak, 
1973). The model term showed a significant 
relationship, with F value of 158.97 and p-value 
of 0.0011, which was less than 0.05.  
 
Effect of  independent variables on 
disintegration time 
ODT is design to provide fast action. It 
is therefore must be rapidly disintegrated inside 
the mouth (Panigrahi dan Behera, 2010). The 
US FDA recommends disintegration time for 
ODT must be less than or equals to 30 
seconds, as stated in the USP disintegration test 
(FDA Guidance, 2008). All formulas in the 
present study had disintegration time < 30s 
(Table III). Disintegration time data in Table 
III can be made in an equation. The equation 
(Table IV) and the contour plot of 
disintegration time ( Figure 6). 
Quadratic model term showed a 
significant relationship with F value = 407.17  
and p-value=0.0024. The use of single super-
disintegrant, either Ac-Di-Sol or Kollidon CL, 
accelerated disintegration time, indicated by the 
positive sign in the equation (9), hence the onset 
Tabel IV Effect of independent variables in equation  
 
Parameter Equation 
Tablet friability (%) Y1 = 1.00*A+0.77*B-1.11*A*B.........(7) 
Wetting time (second) Y2 = 8.19*A+27.25*B ........(8) 
Disintegrating time (second) Y3 = 17.45*A+17.37*B-16.41*A*B.........(9) 
Cumulative drug release in 60s (%) logY4=1.9*A+1.77*B-0.14*A*B-1.84*A*B*(A-B)........(10) 
 
Where A= number of Ac-Di-Sol used, B= number of Kollidon CL used. 
 
Table V. The values from four parameters of ODT 
 
Name Goal Lower limit Upper limit 
Friability (%) Minimize 0.63 1 
Disintegrating Time Minimize 13.28 30 
Wetting Time Minimize 8.72 60 
% Cumulative of meloxicam release in 60s Maximize 47.08 100 
 
Table VI. Optimum formula and verification results with predicted and observed experimental 
values analyzed using OpenStat software 
 
Parameter Predicted values Experimental values p-value 
Friability (%) 0.62 0.63±0.32 0.96 
Wetting Time (sec) 22.10 22.60±0.25 0.07 
Disintegrating Time (sec) 14.16 14.28±0.36 0.62 
% Cumulative of drug release in 60s 88.48 89.06±0.42 0.14 
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of action become more rapid. On the other 
hand, the combination use of both super-
disintegrants decelerated disintegration           
time, indicated by the negative sign in the 
equation.  
Effect of  independent variables on drug 
dissolution 
F1-F5 were subjected for drug release 
study. Figure 5 shows dissolution profile of 
nanoparticle meloxicam ODT during the 1st, 
3rd, 5th, 10th, 15th, 20th, 25th, and 30th min. It can 
 
 
Figure 6. Contour Plot of (A) Friablity; (B) Wetting Time; (C) Disintegrating Time; (D) % 
Cumulative of meloxicam release in 60s 
 
 
 
 
Figure 7. Superimposed contour plot of tablet friability, wetting time, disintegration time, and % 
cumulative of drug release after 60s 
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be seen that in the first minute a great amount 
of meloxicam was released, approximately 
47.08-89.5%, because of the presence of 
superdisintegrant(s). Ac-Di-Sol has double 
mechanisms, that are absorbing water and 
rapidly swelling, whereas Kollidon CL            
has hydrophilic property, quickly dispersed,  
and swells immediately after contacting water 
without forming a gel. Moreover, Kollidon CL 
has a porous structure that increases 
disintegrating time and accelerates tablet 
wetting by water (Mohamed et al., 2012).          
Based on the cumulative dissolution of nano-
particle meloxicam ODT in 60 seconds in 
Table III, it can be made into an equation 
(Table IV). The contour plot can be seen in 
figure 6. 
Cubical model analysis showed a 
significant relationship with F value = 7521.07 
and p-value = 0.0085. The equation (10) 
depicts the influence of each factor and the 
interaction between Ac-Di-Sol and Kollidon 
CL. Single use of superdisintegrant increased 
the amount of meloxicam released after 60 
seconds, while the combination use of 
superdisintegrants decreased the percent 
cumulative drug release. In the equation 10, the 
coefficient of Ac-Di-Sol was the highest and 
therefore ODT formula containing this 
superdisintegrant had the highest drug release. 
This finding was in line with friability and 
disintegrating tests where ODT formula with 
only Ac-Di-Sol superdisintegrant provided a 
dominant response to the increase of friability 
and disintegrating time. 
 
Determination of optimum formula 
The results from the studies of friability, 
wetting time, disintegrating time, and % 
cumulative drug release after 60 seconds were 
analyzed with Design Expert and resulted in a 
graph of mixed components, as showed in 
Figure 7. Three types of goal (range, maximize, 
and minimize) were defined for each parameter 
(Table V). 
The optimization demonstrated that the 
optimum formula for nanoparticle meloxicam 
ODT had the proportion of Ac-Di-
Sol:Kollidon CL of 4.05mg :10.95mg, 
respectively, with desirability of 0.867. This 
optimum formula was verified further by re- 
formulating the ODT and evaluating its 
physical characteristics, including the friability, 
wetting time, disintegration time, and % 
cumulative of meloxicam dissolved after 60 
seconds. 
No significant differences were found 
between predicted versus observed values across 
four parameters (Table VI), thus proving the 
accuracy of current design. 
 
CONCLUSION 
The present study asserted that 
evaluation of the effects of the use of different 
superdisintegrants in terms of type and 
proportion on the characteristics of ODT 
formulas is important. The combination of Ac-
Di-Sol of 4.05mg and Kollidon CL of 10.95mg 
produced optimum ODT-based on the 
evaluation of tablet characteristics, including 
the friability, wetting time, disintegration time, 
and % cumulative of meloxicam dissolved after 
60 seconds. There was no difference between 
predicted value and observed value after 
verification.  
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